A Palfreeman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A Palfreeman

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Neurology|February 23, 2011

Antiretroviral therapy CNS penetration and HIV-1-associated CNS diseaseL Garvey, A Winston, J Walsh, et al.

HIV Medicine|February 18, 2014

British HIV Association guidelines for HIV-associated malignancies 2014Mark Bower, A Palfreeman, Maryam Alfa-Wali, et al.

Plos One|November 13, 2015

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 StudyD Raben, A Mocroft, M Rayment, et al.

Lancet (London, England)|December 17, 2009

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial, P Mugyenyi, A S Walker, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Neurology|February 23, 2011

Antiretroviral therapy CNS penetration and HIV-1-associated CNS diseaseL Garvey, A Winston, J Walsh, et al.

HIV Medicine|February 18, 2014

British HIV Association guidelines for HIV-associated malignancies 2014Mark Bower, A Palfreeman, Maryam Alfa-Wali, et al.

Plos One|November 13, 2015

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 StudyD Raben, A Mocroft, M Rayment, et al.

Lancet (London, England)|December 17, 2009

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial, P Mugyenyi, A S Walker, et al.

Pageof 2